Breaking News

BioClinica Inks eClinical Contracts

By Kristin Brooks | March 26, 2014

To provide enterprise-wide technology and support services

BioClinica, Inc. has recently signed multi-year contract renewals valued at $30 million with two major pharmaceutical companies for its cloud-based technologies and services across its eClinical products.  
Under the first contract, BioClinica will provide resources and subject matter services in clinical supply chain distribution systems and processes that extend to several thousand investigators using Interactive Response Technology (IRT) worldwide.
In the second agreement, BioClinica’s OnPoint CTMS and Express EDC technologies will be deployed for clinical operations including data management, study design, and related professional services that support global clinical studies. Enterprise-wide implementation of cloud-based technologies is also currently underway for each organization.
“Large back-to-back awards like this demonstrate that BioClinica lives up to the high expectations of top tier pharma,” said BioClinica’s president of eClinical Solutions Peter Benton. “BioClinica technologies accommodate the high volume of studies conducted by large life science companies and enable sponsors to drive their research forward.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important